-
公开(公告)号:US12180544B2
公开(公告)日:2024-12-31
申请号:US17560928
申请日:2021-12-23
Inventor: Jingyue Ju , Huanyan Cao , Zengmin Li , Qinglin Meng , Jia Guo , Shenglong Zhang , Lin Yu
Abstract: This invention provides novel azido linkers for deoxynucleotide analogues having a detectable marker attached thereto.
-
公开(公告)号:US12145960B2
公开(公告)日:2024-11-19
申请号:US17287255
申请日:2019-10-24
Applicant: Singular Genomics Systems, Inc.
Inventor: Ronald Graham , Olga Adelfinskaya , Megha Cila , Rodrigo Rodriguez , Abrehet Abdu , Eli N. Glezer
IPC: C07H19/14 , C07H19/10 , C07H19/20 , C12Q1/68 , C12Q1/6869 , C12Q1/6876
Abstract: Disclosed herein, interalia, are compounds, compositions, and methods of using the same for the sequencing of a nucleic acid.
-
公开(公告)号:US12071662B2
公开(公告)日:2024-08-27
申请号:US18313227
申请日:2023-05-05
Applicant: Illumina Cambridge Limited
Inventor: Elena Cressina , Antoine Francais , Xiaohai Liu
IPC: C12Q1/68 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/14 , C07H19/16 , C07H19/20 , C07H21/00 , C07H21/04 , C12Q1/6809 , C12Q1/6816 , C12Q1/6869
CPC classification number: C12Q1/6869 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/14 , C07H19/16 , C07H19/20 , C07H21/00 , C07H21/04 , C12Q1/6809 , C12Q1/6816 , C12Q1/6869 , C12Q2525/117 , C12Q2535/122
Abstract: The present disclosure relates to new nucleotide and oligonucleotide compounds and their use in nucleic acid sequencing applications.
-
公开(公告)号:US20240174709A1
公开(公告)日:2024-05-30
申请号:US18522886
申请日:2023-11-29
Applicant: Singular Genomics Systems, Inc.
Inventor: Ronald Graham , Olga Adelfinskaya , Megha Cila , Rodrigo Rodriguez , Abrehet Abdu , Eli N. Glezer
IPC: C07H19/14 , C07H19/10 , C07H19/20 , C12Q1/6869 , C12Q1/6876
CPC classification number: C07H19/14 , C07H19/10 , C07H19/20 , C12Q1/6869 , C12Q1/6876
Abstract: Disclosed herein, inter alia, are compounds, compositions, and methods of using the same for the sequencing of a nucleic acid.
-
公开(公告)号:US11958877B2
公开(公告)日:2024-04-16
申请号:US18178802
申请日:2023-03-06
Applicant: Singular Genomics Systems, Inc.
Inventor: Ronald Graham , Olga Adelfinskaya , Megha Cila , Rodrigo Rodriguez , Abrehet Abdu , Eli N. Glezer
IPC: C07H19/14 , C07H19/10 , C07H19/20 , C12Q1/6869 , C12Q1/6876
CPC classification number: C07H19/14 , C07H19/10 , C07H19/20 , C12Q1/6869 , C12Q1/6876
Abstract: Disclosed herein, interalia, are compounds, compositions, and methods of using the same for the sequencing of a nucleic acid.
-
公开(公告)号:US20230257908A1
公开(公告)日:2023-08-17
申请号:US17913458
申请日:2021-03-25
Applicant: TECHNISCHE UNIVERSITAET DORTMUND
Inventor: Andreas BRUNSCHWEIGER , Mateja KLIKA SKOPIC , Marco POTOWSKI , Verena Barbara Katharina KUNIG
IPC: C40B40/06 , C07H19/052 , C07H19/14 , C07H19/167 , C07H21/04
CPC classification number: C40B40/06 , C07H19/14 , C07H19/052 , C07H19/167 , C07H21/04
Abstract: A compound library may include a plurality of conjugate molecules, said conjugates comprising a small organic molecule covalently coupled to a nucleic acid moiety. The nucleic acid moiety may include or consist of 7-deazapurines and/or 7-deaza-8-azapurines, and, optionally, modified pyrimidine nucleotides and/or unmodified pyrimidine nucleotides. Further, a library for screening compounds binding to a target molecule and methods of synthesizing said library is also disclosed.
-
公开(公告)号:US11649260B2
公开(公告)日:2023-05-16
申请号:US17842135
申请日:2022-06-16
Applicant: Hongene Biotech Corporation
Inventor: Xiaoyang Guan , David Yu , Ruiming Zou , Xiaoling Zheng , John Liu , Aldrich N. K. Lau , Wing C. Poon , Gang Zhao , Gengyu Du , Yun-Chiao Yao
CPC classification number: C07H19/06 , A61K47/549 , A61K48/0033 , C07H1/00 , C07H19/14
Abstract: Embodiments of the present application relate to N-acetylgalactosamine-conjugated nucleosides. In particular, the N-acetylgalactosamine is installed on the nucleobase of the nucleosides through a wide variety of linkers. Methods of making N-acetylgalactosamine-conjugated nucleosides are also disclosed herein. N-acetylgalactosamine is a well-defined liver-targeted moiety and N-acetylgalactosamine-conjugated nucleosides may be used in the preparation of targeted delivery of oligonucleotide-based therapeutics.
-
公开(公告)号:US20230025669A1
公开(公告)日:2023-01-26
申请号:US17856441
申请日:2022-07-01
Applicant: Illumina Cambridge Limited
Inventor: Nikolai Nikolaevich ROMANOV , Patrick MCCAULEY , Carole ANASTASI , Xiaolin WU , Niall HYNES
IPC: C07D417/04 , C07D405/04 , C07D413/04 , C07H19/10 , C07H19/14 , C12Q1/6876
Abstract: The present application relates to secondary amine-substituted coumarin compounds and their uses as fluorescent labels. The compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.
-
公开(公告)号:US20220411860A1
公开(公告)日:2022-12-29
申请号:US17373295
申请日:2021-07-12
Applicant: Jingyue Ju , Xiaoxu Li , Xin Chen , Zengmin Li , Shiv Kumar , Shundi Shi , Cheng Guo , Jianyi Ren , Min-Kang Hsieh , Minchen Chien , Chuanjuan Tao , Ece Erturk , Sergey Kalachikov , James J. Russo
Inventor: Jingyue Ju , Xiaoxu Li , Xin Chen , Zengmin Li , Shiv Kumar , Shundi Shi , Cheng Guo , Jianyi Ren , Min-Kang Hsieh , Minchen Chien , Chuanjuan Tao , Ece Erturk , Sergey Kalachikov , James J. Russo
IPC: C12Q1/6869 , C07H19/10 , C07H19/14 , C07H19/20
Abstract: Disclosed herein, inter alfa, are compounds, compositions, and methods of use thereof in the sequencing of a nucleic acid.
-
10.
公开(公告)号:US20220233566A1
公开(公告)日:2022-07-28
申请号:US17619379
申请日:2020-06-17
Applicant: TAIHO PHARMACEUTICAL CO., LTD.
Inventor: Hitoshi MIYAKOSHI , Nozomu TANAKA , Yu KOBAYAKAWA
IPC: A61K31/7064 , C07H19/14 , A61P35/00 , A61K31/495 , A61N5/10
Abstract: There is provided a novel carbonate compound of a nucleoside having a pyrrolopyrimidine skeleton having an excellent antitumor effect, or a pharmaceutically acceptable salt thereof and a method for preventing and/or treating a tumor in combination with an alkylating agent and/or a radiation therapy. According to one aspect of the present invention, there is provided a compound represented by the following general formula (1): or a pharmaceutically acceptable salt thereof, and a method for preventing and/or treating a tumor in combination with an alkylating agent and/or a radiation therapy.
-
-
-
-
-
-
-
-
-